Human Metabolome Technologies, Inc. (TYO:6090)
696.00
-4.00 (-0.57%)
Apr 28, 2026, 3:30 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.92 billion as of April 28, 2026. Its market cap has increased by 1.24% in one year.
Market Cap
3.92B
Enterprise Value
2.81B
Revenue
1.43B
Ranking
n/a
PE Ratio
19.41
Stock Price
696.00
Market Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.92B, a decrease of -64.53%. That is a compound annual growth rate of -8.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.92B | 4.84% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.25T |
| HOYA Corporation | 9.71T |
| Takeda Pharmaceutical Company | 8.24T |
| Otsuka Holdings | 5.61T |
| MedRx | 4.75B |
| Transgenic Group | 4.36B |
| Ribomic | 4.34B |
| teno. Holdings Company | 4.11B |